CLINICAL_TRIALS
research
· 2025-11-24
Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
Summary
A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cells in autoimmune dis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: TScan Therapeutics, Inc. | Conditions: Autoimmune Diseases, Ulcerative Colitis | Status: RECRUITING